Cargando…

Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion

OBJECTIVE: To assess the response of serum triglycerides (TG) to continuous insulin infusion (CII) in adults with hypertriglyceridemia-associated acute pancreatitis (HTGP). METHODS: Retrospective analysis of TG response to standardized CII therapy in 77 adults admitted to intensive care with TG >...

Descripción completa

Detalles Bibliográficos
Autores principales: Pulipati, Vishnu Priya, Amblee, Ambika, Yap, Sara Elizabeth T., Shaka, Hafeez, Tahsin, Bettina, Fogelfeld, Leon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631651/
https://www.ncbi.nlm.nih.gov/pubmed/34847179
http://dx.doi.org/10.1371/journal.pone.0260495
_version_ 1784607605078884352
author Pulipati, Vishnu Priya
Amblee, Ambika
Yap, Sara Elizabeth T.
Shaka, Hafeez
Tahsin, Bettina
Fogelfeld, Leon
author_facet Pulipati, Vishnu Priya
Amblee, Ambika
Yap, Sara Elizabeth T.
Shaka, Hafeez
Tahsin, Bettina
Fogelfeld, Leon
author_sort Pulipati, Vishnu Priya
collection PubMed
description OBJECTIVE: To assess the response of serum triglycerides (TG) to continuous insulin infusion (CII) in adults with hypertriglyceridemia-associated acute pancreatitis (HTGP). METHODS: Retrospective analysis of TG response to standardized CII therapy in 77 adults admitted to intensive care with TG >1000 mg/dL and HTGP. RESULTS: Participants had initial TG 3869.0 [2713.5, 5443.5] mg/dL and were 39.3 ± 9.7 years old, 66.2% males, 58.4% Hispanic, BMI 30.2 [27.0, 34.8] kg/m(2), 74.0% with diabetes mellitus (DM) and 50.6% with excess alcohol use. TG-goal, defined as ≤1,000 ± 100 mg/dL, was achieved in 95%. Among the 73 TG-goal achievers (responders), 53.4% reached TG-goal in <36 hours after CII initiation (rapid responders). When compared to slow responders taking≥36 hours, rapid responders had lower initial TG (2862.0 [1965.0, 4519.0] vs 4814.5 [3368.8, 6900.0] mg/dL), BMI (29.4 [25.9, 32.8] vs 31.9 [28.2, 38.3] kg/m(2)), DM prevalence (56.4 vs 94.1%), and reached TG-50% (half of respective initial TG) faster (12.0 [6.0, 17.0] vs 18.5 [13.0, 32.8] hours). Those with DM (n = 57) vs non-DM (n = 20) were obese (31.4 [28.0, 35.6] vs 27.8 [23.6, 30.3] kg/m(2)), took longer to reach TG-final (41.0 [25.0, 60.5] vs 14.5 [12.5, 25.5] hours) and used more daily insulin (1.7 [1.3, 2.1] vs 1.1 [0.5, 1.9] U/kg/day). Among those with DM, the rapid responders had higher daily use of insulin vs slow responders 1.9 [1.4, 2.3] vs 1.6 [1.1, 1.8] U/kg/day. All results significant. In multivariable analysis, predictors of faster TG response were absence of DM, lower BMI and initial TG. CONCLUSION: CII was effective in reaching TG-goal in 95% of patients with HTGP. Half achieved TG-goal within 36 hours. Presence of DM, higher BMI and initial TG slowed the time to reach TG-goal. These baseline parameters and rate of decline to TG-50% may be real-time indicators to initiate and adjust the CII for quicker response.
format Online
Article
Text
id pubmed-8631651
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-86316512021-12-01 Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion Pulipati, Vishnu Priya Amblee, Ambika Yap, Sara Elizabeth T. Shaka, Hafeez Tahsin, Bettina Fogelfeld, Leon PLoS One Research Article OBJECTIVE: To assess the response of serum triglycerides (TG) to continuous insulin infusion (CII) in adults with hypertriglyceridemia-associated acute pancreatitis (HTGP). METHODS: Retrospective analysis of TG response to standardized CII therapy in 77 adults admitted to intensive care with TG >1000 mg/dL and HTGP. RESULTS: Participants had initial TG 3869.0 [2713.5, 5443.5] mg/dL and were 39.3 ± 9.7 years old, 66.2% males, 58.4% Hispanic, BMI 30.2 [27.0, 34.8] kg/m(2), 74.0% with diabetes mellitus (DM) and 50.6% with excess alcohol use. TG-goal, defined as ≤1,000 ± 100 mg/dL, was achieved in 95%. Among the 73 TG-goal achievers (responders), 53.4% reached TG-goal in <36 hours after CII initiation (rapid responders). When compared to slow responders taking≥36 hours, rapid responders had lower initial TG (2862.0 [1965.0, 4519.0] vs 4814.5 [3368.8, 6900.0] mg/dL), BMI (29.4 [25.9, 32.8] vs 31.9 [28.2, 38.3] kg/m(2)), DM prevalence (56.4 vs 94.1%), and reached TG-50% (half of respective initial TG) faster (12.0 [6.0, 17.0] vs 18.5 [13.0, 32.8] hours). Those with DM (n = 57) vs non-DM (n = 20) were obese (31.4 [28.0, 35.6] vs 27.8 [23.6, 30.3] kg/m(2)), took longer to reach TG-final (41.0 [25.0, 60.5] vs 14.5 [12.5, 25.5] hours) and used more daily insulin (1.7 [1.3, 2.1] vs 1.1 [0.5, 1.9] U/kg/day). Among those with DM, the rapid responders had higher daily use of insulin vs slow responders 1.9 [1.4, 2.3] vs 1.6 [1.1, 1.8] U/kg/day. All results significant. In multivariable analysis, predictors of faster TG response were absence of DM, lower BMI and initial TG. CONCLUSION: CII was effective in reaching TG-goal in 95% of patients with HTGP. Half achieved TG-goal within 36 hours. Presence of DM, higher BMI and initial TG slowed the time to reach TG-goal. These baseline parameters and rate of decline to TG-50% may be real-time indicators to initiate and adjust the CII for quicker response. Public Library of Science 2021-11-30 /pmc/articles/PMC8631651/ /pubmed/34847179 http://dx.doi.org/10.1371/journal.pone.0260495 Text en © 2021 Pulipati et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Pulipati, Vishnu Priya
Amblee, Ambika
Yap, Sara Elizabeth T.
Shaka, Hafeez
Tahsin, Bettina
Fogelfeld, Leon
Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion
title Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion
title_full Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion
title_fullStr Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion
title_full_unstemmed Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion
title_short Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion
title_sort hypertriglyceridemia-associated acute pancreatitis: response to continuous insulin infusion
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631651/
https://www.ncbi.nlm.nih.gov/pubmed/34847179
http://dx.doi.org/10.1371/journal.pone.0260495
work_keys_str_mv AT pulipativishnupriya hypertriglyceridemiaassociatedacutepancreatitisresponsetocontinuousinsulininfusion
AT ambleeambika hypertriglyceridemiaassociatedacutepancreatitisresponsetocontinuousinsulininfusion
AT yapsaraelizabetht hypertriglyceridemiaassociatedacutepancreatitisresponsetocontinuousinsulininfusion
AT shakahafeez hypertriglyceridemiaassociatedacutepancreatitisresponsetocontinuousinsulininfusion
AT tahsinbettina hypertriglyceridemiaassociatedacutepancreatitisresponsetocontinuousinsulininfusion
AT fogelfeldleon hypertriglyceridemiaassociatedacutepancreatitisresponsetocontinuousinsulininfusion